ArticleDiagnostics (Basel, Switzerland)2025

Diagnostic Evaluation of an Increased Risk of Developing Small Intestinal Bacterial Overgrowth Associated with Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Dual GLP-1/GIP Receptor Agonists: A Global Retrospective Multicenter Cohort Analysis.

Yan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.